Mereo Biopharma Group Plc logo

Mereo Biopharma Group Plc share price today

(MREO)

Mereo Biopharma Group Plc share price is $3.76 & ₹322.65 as on 7 Jan 2025, 2.30 'hrs' IST

$3.76

0.03

(0.8%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Mereo Biopharma Group Plc share price in Dollar and Rupees. Guide to invest in Mereo Biopharma Group Plc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Mereo Biopharma Group Plc, along with analyst recommendations, forecasts, and comprehensive financials.

Mereo Biopharma Group Plc share price movements

  • Today's Low: $3.68
    Today's High: $3.83

    Day's Volatility :3.88%

  • 52 Weeks Low: $2.25
    52 Weeks High: $5.02

    52 Weeks Volatility :55.18%

Mereo Biopharma Group Plc Returns

PeriodMereo Biopharma Group PlcIndex (Russel 2000)
3 Months
-10.34%
0.0%
6 Months
-3.12%
0.0%
1 Year
45.14%
0.0%
3 Years
186.92%
-19.8%

Mereo Biopharma Group Plc Key Statistics

in dollars & INR

Previous Close
$3.73
Open
$3.8
Today's High
$3.8285
Today's Low
$3.68
Market Capitalization
$630.8M
Today's Volume
$1.0M
52 Week High
$5.02
52 Week Low
$2.25
Revenue TTM
$1000.0K
EBITDA
$-37.3M
Earnings Per Share (EPS)
$-0.25
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-48.47%

How to invest in Mereo Biopharma Group Plc from India?

It is very easy for Indian residents to invest directly in Mereo Biopharma Group Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Mereo Biopharma Group Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Mereo Biopharma Group Plc or MREO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Mereo Biopharma Group Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Mereo Biopharma Group Plc shares which would translate to 0.228 fractional shares of Mereo Biopharma Group Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Mereo Biopharma Group Plc, in just a few clicks!

Returns in Mereo Biopharma Group Plc for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Mereo Biopharma Group Plc investment value today

Current value as on today

₹1,49,526

Returns

₹49,526

(+49.53%)

Returns from Mereo Biopharma Group Plc Stock

₹46,304 (+46.3%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Mereo Biopharma Group Plc

55%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Mereo Biopharma Group Plc on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 55% more investors are searching Mereo Biopharma Group Plc in the last 30 days versus the previous period.

Global Institutional Holdings in Mereo Biopharma Group Plc

  • Rubric Capital Management LP

    9.87%

  • HHG PLC

    7.96%

  • Adage Capital Partners Gp LLC

    6.26%

  • Rock Springs Capital Management LP

    6.15%

  • Mangrove Partners

    5.63%

  • Deerfield Management Co

    4.33%

Analyst Recommendation on Mereo Biopharma Group Plc

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Mereo Biopharma Group Plc(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Mereo Biopharma Group Plc

What analysts predicted

Upside of 92.02%

Current:

$3.76

Target:

$7.22

Insights on Mereo Biopharma Group Plc

  • Price Movement

    In the last 3 years, MREO stock has moved up by 148.7%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 8.79M → 361.1K (in $), with an average decrease of 63.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -6.04M → -15.00M (in $), with an average decrease of 35.8% per quarter

Mereo Biopharma Group Plc Technicals Summary

Sell

Neutral

Buy

Mereo Biopharma Group Plc is currently in a neutral trading position according to technical analysis indicators.

Mereo Biopharma Group Plc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Mereo Biopharma Group Plc
-1.84%
-3.12%
45.14%
186.92%
63.38%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Mereo Biopharma Group Plc
NA
NA
NA
-0.03
-0.48
-0.24
NA
0.51
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Mereo Biopharma Group Plc
Buy
$630.8M
63.38%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Mereo Biopharma Group Plc

mereo is a new uk-based speciality biopharmaceutical company focussed on the acquisition and rapid development of innovative medicines that have the potential to transform patient quality of life and improve human health. mereo intends to optimise the commercial value of programmes by entering into partnering deals at key value inflection points or, for selected opportunities, commercialising products itself. mereo is building a strong pipeline of innovative medicines, particularly focused in rare and specialist disease areas, through the acquisition of validated, mid-stage development programmes from large biopharmaceutical companies. mereo has access to an extensive network of experts with experience across multiple clinical disciplines for the clinical development of its portfolio.
Organization
Mereo Biopharma Group Plc
Employees
33
CEO
Dr. Denise Vera Scots-Knight Ph.D.
Industry
Biotechnology

Management People of Mereo Biopharma Group Plc

NameTitle
Dr. Denise Vera Scots-Knight Ph.D.
Co-Founder, CEO & Executive Director
Mr. Charles Edward Sermon
Co-Founder, General Counsel, Business Development & Company Secretary
Ms. Christine Fox CPA
Chief Financial Officer
Dr. John P. Richard M.B.A.
Co-Founder & Chief Business Officer
Dr. John A. Lewicki Ph.D.
Chief Scientific Officer
Dr. Jackie Parkin
Senior VP & Therapeutic Head
Ms. Alexandra Hughes-Wilson
Chief of Patient Access & Commercial Planning
Dr. Suba Krishnan
Senior Vice President of Clinical Development
Mr. Bo Kara
Senior VP and Head of Pharmaceutical Development & CMC

Important FAQs about investing in Mereo Biopharma Group Plc from India :

What is Mereo Biopharma Group Plc share price today?

Mereo Biopharma Group Plc share price today stands at $3.76, Open: $3.80 ; Previous Close: $3.73 ; High: $3.83 ; Low: $3.68 ; 52 Week High: $5.02 ; 52 Week Low: $2.25. The stock opens at $3.80, after a previous close of $3.73. The stock reached a daily high of $3.83 and a low of $3.68, with a 52-week high of $5.02 and a 52-week low of $2.25.

Can Indians buy Mereo Biopharma Group Plc shares?

Yes, Indians can invest in the Mereo Biopharma Group Plc (MREO) from India.

With INDmoney, you can buy Mereo Biopharma Group Plc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Mereo Biopharma Group Plc at zero transaction cost.

How can I buy Mereo Biopharma Group Plc shares from India?

It is very easy to buy Mereo Biopharma Group Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Mereo Biopharma Group Plc be purchased?

Yes, you can buy fractional shares of Mereo Biopharma Group Plc with INDmoney app.

What are the documents required to start investing in Mereo Biopharma Group Plc stocks?

To start investing in Mereo Biopharma Group Plc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Mereo Biopharma Group Plc

Today’s highest price of Mereo Biopharma Group Plc (MREO) is $3.83.

Today’s lowest price of Mereo Biopharma Group Plc (MREO) is $3.68.

What is today's market capitalisation of Mereo Biopharma Group Plc

Today's market capitalisation of Mereo Biopharma Group Plc MREO is 630.8M

What is the 52 Week High and Low Range of Mereo Biopharma Group Plc

  • 52 Week High

    $5.02

  • 52 Week Low

    $2.25

What are the historical returns of Mereo Biopharma Group Plc?

  • 1 Month Returns

    -1.84%

  • 3 Months Returns

    -3.12%

  • 1 Year Returns

    45.14%

  • 5 Years Returns

    63.38%

Who is the Chief Executive Officer (CEO) of Mereo Biopharma Group Plc

Dr. Denise Vera Scots-Knight Ph.D. is the current Chief Executive Officer (CEO) of Mereo Biopharma Group Plc.